checkAd

     132  0 Kommentare Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic AVNU - Seite 3

    Triferic is a registered trademark of Rockwell Medical, Inc.  Triferic AVNU is pending with the U.S. Patent and Trademark Office. 

    CONTACTS

    Investors:
    Argot Partners
    212.600.1902
    Rockwell@argotpartners.com

    Lesen Sie auch

    Media:
    David Rosen
    Argot Partners
    212.600.1902
    david.rosen@argotpartners.com 


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic AVNU - Seite 3 WIXOM, Mich., May 26, 2020 (GLOBE NEWSWIRE) - Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the …